Contact
Please use this form to send email to PR contact of this press release:
TriCelX, ADCAN Pharma & DAS Holding Execute Tripartite MOU & Form UAE Joint Venture TriCelX Biotherapeutic Portfolio
TO:
Kathryn Dziedzic
TriCelX
+1 970-305-1165